Detalles de la búsqueda
1.
A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study.
BMC Cancer;
22(1): 503, 2022 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35524214
2.
The clinical impact of concomitant medication use on the outcome of postoperative recurrent non-small-cell lung cancer in patients receiving immune checkpoint inhibitors.
PLoS One;
17(2): e0263247, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35130287
3.
Immunonutritional Indices in Non-small-cell Lung Cancer Patients Receiving Adjuvant Platinum-based Chemotherapy.
Anticancer Res;
41(10): 5157-5163, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34593467
4.
Clinical impact of probiotics on the efficacy of anti-PD-1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weighting.
Int J Cancer;
149(2): 473-482, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33720422
5.
Limb arteriolar vasculitis induced by pembrolizumab plus chemotherapy in a patient with lung cancer.
Int Cancer Conf J;
10(1): 83-86, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33489708
6.
Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
Ann Thorac Surg;
109(3): 914-920, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31655044
7.
Prognosis of Early-stage Part-solid and Pure-solid Lung Adenocarcinomas.
Anticancer Res;
39(5): 2665-2670, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31092466
8.
A novel prognostic marker in patients with non-small cell lung cancer: musculo-immuno-nutritional score calculated by controlling nutritional status and creatine kinase.
J Thorac Dis;
11(3): 927-935, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31019782
9.
Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients.
Ann Surg Oncol;
26(6): 1916-1924, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30815801
10.
The Significance of CD44 Variant 9 in Resected Lung Adenocarcinoma: Correlation with Pathological Early-Stage and EGFR Mutation.
Ann Surg Oncol;
26(5): 1544-1551, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30798450
11.
Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors.
Cancer Sci;
110(4): 1340-1351, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30724423
12.
Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?
Surg Today;
49(3): 197-205, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30610361
13.
Differences in PD-L1 expression on tumor and immune cells between lung metastases and corresponding primary tumors.
Surg Oncol;
27(4): 637-641, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30449485
14.
PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung Cancer.
Anticancer Res;
38(10): 5897-5901, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30275216
15.
Prognostic Impact of PD-L2 Expression and Association with PD-L1 in Patients with Small-cell Lung Cancer.
Anticancer Res;
38(10): 5903-5907, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30275217
16.
Radiological Features of Programmed Cell Death-Ligand 2-positive Lung Adenocarcinoma: A Single-institution Retrospective Study.
In Vivo;
32(6): 1541-1550, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30348714
17.
Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma.
Eur J Cancer;
101: 20-29, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30014971
18.
Phase II study of ceritinib in alectinib-pretreated patients with anaplastic lymphoma kinase-rearranged metastatic non-small-cell lung cancer in Japan: ASCEND-9.
Cancer Sci;
109(9): 2863-2872, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29959809
19.
Prevalence of Enhancer of Zeste Homolog 2 in Patients with Resected Small Cell Lung Cancer.
Anticancer Res;
38(6): 3707-3711, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29848731
20.
Radiological Features of Brain Metastases from Non-small Cell Lung Cancer Harboring EGFR Mutation.
Anticancer Res;
38(6): 3731-3734, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29848735